Harvard Apparatus Regenerative Technology, Inc.
For the period ended Jun 30, 2026. Filed Aug 13, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2026 · Filed Aug 13, 2026
HRGNStored price and day change unavailable
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Balance Sheets
(in thousands, except share and par value data)
| June 30, | December 31, | |
|---|---|---|
| 2026 | 2025 | |
| (Unaudited) | ||
| ASSETS | ||
| Current assets: | ||
| Cash and cash equivalents | $351 | $1,352 |
| Accounts receivable | 9 | 16 |
| Inventory | — | 16 |
| Prepaid research and development | 83 | 18 |
| Prepaid expenses and other current assets | 346 | 427 |
| Total current assets | 789 | 1,829 |
| Property, plant and equipment, net | 4 | 6 |
| Right-of-use assets, net | 141 | 195 |
| Long-term prepaid contracts | 751 | 647 |
| Total assets | $1,685 | $2,677 |
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||
| Current liabilities: | ||
| Accounts payable | $757 | $454 |
| Accrued and other current liabilities | 1,013 | 532 |
| Deferred revenue | 603 | 252 |
| Insurance premium financing payable | 46 | 183 |
| Convertible debt – related party | 500 | — |
| Operating lease liability | 123 | 113 |
| Total current liabilities | 3,042 | 1,534 |
| Operating lease liability, net of current portion | 22 | 86 |
| Total liabilities | 3,064 | 1,620 |
| Commitments and contingencies (Note 6) | ||
| Stockholders’ (deficit) equity: | ||
| Common stock, par value $0.01 per share, 60,000,000 shares authorized; 17,580,744 shares issued and outstanding at each of June 30, 2026 and December 31, 2025 | 176 | 176 |
| Additional paid-in capital | 108,305 | 107,450 |
| Accumulated deficit | (109,853) | (106,557) |
| Accumulated other comprehensive loss | (7) | (12) |
| Total stockholders’ (deficit) equity | (1,379) | 1,057 |
| Total liabilities and stockholders’ (deficit) equity | $1,685 | $2,677 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.